Table 2:
Associations between fatigue and selected variables in patients with autoimmune skin diseases
| SLE | CLE | ADM | AIBD | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |
| Demographics | ||||||||||||
| Mean age | 1.01 | 0.99 to 1.04 | 0.36 | 0.10 | 0.98 to 1.02 | 0.69 | 0.995 | 0.97 to 1.02 | 0.73 | 1.01 | 0.98 to 1.04 | 0.46 |
| Female Sex | 6.36 | 1.36 to 29.69 | 0.02 | 3.21 | 1.48 to 6.97 | 0.003 | 1.25 | 0.36 to 4.31 | 0.72 | 1.09 | 0.42 to 2.87 | 0.86 |
| Smoking status | 1.33 | 0.62 to 2.83 | 0.47 | 1.55 | 0.87 to 2.78 | 0.14 | 3.41 | 0.78 to 14.99 | 0.10 | 0.75 | 0.07 to 7.64 | 0.81 |
| Comorbidities | ||||||||||||
| HTN | 1.38 | 0.67 to 2.84 | 0.38 | 0.91 | 0.44 to 1.86 | 0.79 | 1.57 | 0.65 to 3.80 | 0.65 | 1.35 | 0.51 to 3.62 | 0.55 |
| Diabetes | 1.00 | 1.00 | 2.87 | 0.46 to 17.78 | 0.26 | 0.22 | 0.03 to 1.86 | 0.17 | ||||
| Hypothyroid Disease | 1.14 | 0.39 to 3.31 | 0.81 | 1.08 | 0.44 to 2.64 | 0.87 | 2.63 | 0.96 to 7.20 | 0.06 | 2.00 | 0.49 to 8.22 | 0.34 |
| Medications | ||||||||||||
| Antimalarials | 1.54 | 0.74 to 3.19 | 0.25 | 0.97 | 0.55 to 1.73 | 0.93 | 1.41 | 0.66 to 3.04 | 0.38 | |||
| Immunosuppressants | 0.87 | 0.46 to 1.65 | 0.66 | 2.60 | 1.28 to 5.28 | 0.008 | 0.79 | 0.36 to 1.77 | 0.57 | 0.93 | 0.35 to 2.47 | 0.89 |
| SF-36 Mental Health Score | 0.94 | 0.92 to 0.96 | <0.001 | 0.96 | 0.94 to 0.97 | <0.001 | 0.94 | 0.92 to 0.97 | <0.001 | 0.95 | 0.92 to 0.98 | <0.001 |
AIBD, autoimmune blistering diseases; ADM, amyopathic dermatomyositis; CI, confidence interval; CLE, cutaneous lupus erythematosus; HTN, hypertension; OR, odds ratio; SLE, systemic lupus erythematosus